- Approved for treating acute hepatic porphyria (AHP) in adults and young people aged 12 and older in line with NICE, only if:
- they have clinically confirmed severe recurrent attacks (4 attacks or more within 12 months) and
- the company provides it according to the commercial arrangement.
|